A large RCT in older adults showed the online Rethink My Drink program produced durable reductions in monthly alcohol consumption at 12 months but did not change global cognition.
This trial is clinically useful for reducing alcohol-related brain health risks in older adults but has limited direct value for Parkinson's therapeutic discovery because it excludes PD patients and provides no mechanistic, biomarker, or targetable insights relevant to PD pathogenesis or drug…